CIK 0001776111 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MBX Biosciences, Inc.
Sign in to watch- Ticker
- MBX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 3179893100
- Business address
- 11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President & CEO bought 18,500 shares at $28.41 ($525,663)
- 4 Option exercise President & CEO acquired 28,768 shares (option exercise)
- 4 Grant or award Chief Medical Officer acquired 15,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 15,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 35,250 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise President & CEO acquired 182,859 shares (option exercise)
- 4 Open-market buy President & CEO bought 20,000 shares at $13.64 ($272,790)
- 4 Open-market buy Director bought 20,000 shares at $13.25 ($264,984)
- 4 Open-market buy Director bought 666,666 shares at $18.00 ($11,999,988)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 5 · 99 filings